Oxidized low-density lipoprotein-induced CD147 expression and its inhibition by high-density lipoprotein on platelets in vitro

Thrombosis Research

Volumn 132, Issue 6, 2013, Pages 702-711

  Yang, Sheng Hua ^a   Li, Yun Tian ^a   Du, Da Yong ^a  

^a The 305 Hospital of Chinese PLA   (China)

Author keywords

CD147; EMMPRIN; HDL; ox LDL; Plaque; Platelet

Indexed keywords

CD147 ANTIGEN; CD63 ANTIGEN; HIGH DENSITY LIPOPROTEIN; LIPOCORTIN 5; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY LOX 1; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PADGEM PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL GRANULE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; IN VITRO STUDY; LASER MICROSCOPY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTE STRUCTURE; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION;

ACS; ACUTE CORONARY SYNDROMES; CAD; CD147; CORONARY ARTERY DISEASE; ECM; EMMPRIN; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX METALLOPROTEINASE INDUCER; HDL; HIGH-DENSITY LIPOPROTEIN; MATRIX METALLOPROTEINASES; MMPS; OCS; OPEN CANALICULAR SYSTEM; OX-LDL; OXIDIZED LOW-DENSITY LIPOPROTEIN; PLAQUE; PLATELET; PLATELET-RICH PLASMA; PRP;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD147; BLOOD PLATELETS; CHOLESTEROL, LDL; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MATRIX METALLOPROTEINASE 1; REFERENCE VALUES; SCAVENGER RECEPTORS, CLASS E;

EID: 84889883957     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.10.003     Document Type: Article

References (56)

1. V. Fuster, L. Badimon, J.J. Badimon, and J.H. Chesebro The pathogenesis of coronary artery disease and the acute coronary syndromes N Engl J Med 326 1992 242 250
2. E. Falk, P.K. Shah, and V. Fuster Coronary plaque disruption Circulation 92 1995 657 671
3. J.A. Schaar, J.E. Muller, E. Falk, R. Virmani, V. Fuster, and P.W. Serruys Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece Eur Heart J 25 2004 1077 1082
4. Z.S. Galis, G.K. Sukhova, M.W. Lark, and P. Libby Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques J Clin Invest 94 1994 2493 2503
5. P. Libby Current concepts of the pathogenesis of the acute coronary syndromes Circulation 104 2001 365 372
6. R. Schmidt, A. Bültmann, M. Ungerer, N. Joghetaei, Ö. Bülbül, and S. Thieme Extracellular Matrix Metalloproteinase Inducer Regulates Matrix Metalloproteinase Activity in Cardiovascular Cells Implications in Acute Myocardial Infarction Circulation 113 2006 834 841
7. C. Biswas Tumor cell stimulation of collagenase production by fibroblasts Biochem Biophys Res Commun 109 1982 1026 1034
8. W. Kasinrerk, E. Fiebiger, I. Stefanova, T. Baumruker, W. Knapp, and H. Stockinger Human leukocyte activation antigen M6, a member of the Ig superfamily, is the species homologue of rat OX-47, mouse basigin, and chicken HT7 molecule J Immunol 149 1992 847 854
9. R. Schmidt, A. Bültmann, S. Fischel, A. Gillitzer, P. Cullen, and A. Walch Extracellular Matrix Metalloproteinase Inducer (CD147) Is a Novel Receptor on Platelets, Activates Platelets, and Augments Nuclear Factor kB-Dependent Inflammation in Monocytes Circ Res 102 2008 302 309
10. G.J. Pennings, A.S.C. Yong, and L. Kritharides Expression of EMMPRIN (CD147) on circulating platelets in vivo J Thromb Haemost 8 2010 472 481
11. C. Schulz, M.-L. von Brühl, V. Barocke, P. Cullen, K. Mayer, and R. Okrojek EMMPRIN (CD147/basigin) mediates platelet-monocyte interactions in vivo and augments monocyte recruitment to the vascular wall J Thromb Haemost 9 2011 1007 1019
12. D. Steinberg, S. Parthasarathy, T. Carew, J. Khoo, and J. Witztum Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity N Engl J Med 320 1989 915 924
13. P. Holvoet, A. Mertens, P. Verhamme, K. Bogaerts, G. Beyens, and R. Verhaeghe Circulating Oxidized LDL Is a Useful Marker for Identifying Patients With Coronary Artery Disease Arterioscler Thromb Vasc Biol 21 2001 844 848
14. M.-L. Liu, K. Ylitalo, R. Salonen, J.T. Salonen, and M.-R. Taskinen Hyperlipidemia Families Intima-Media Thickness in Asymptomatic Members of Familial Combined Circulating Oxidized Low-Density Lipoprotein and Its Association With Carotid Arterioscler Thromb Vasc Biol 24 2004 1492 1497
15. S. Ehara, M. Ueda, T. Naruko, K. Haze, A. Itoh, and M. Otsuka Elevated Levels of Oxidized Low Density Lipoprotein Show a Positive Relationship With the Severity of Acute Coronary Syndromes Circulation 103 2001 1955 1960
16. C. Meisinger, J. Baumert, N. Khuseyinova, H. Loewel, and W. Koenig Plasma Oxidized Low-Density Lipoprotein, a Strong Predictor for Acute Coronary Heart Disease Events in Apparently Healthy, Middle-Aged Men From the General Population Circulation 112 2005 651 657
17. M. Anselmi, U. Garbin, P. Agostoni, M. Fusaro, A.F. Pasini, and C. Nava Plasma levels of oxidized-low-density lipoproteins are higher in patients with unstable angina and correlated with angiographic coronary complex plaques Atherosclerosis 185 2006 114 120
18. E.A. Podrez, T.V. Byzova, M. Febbraio, R.G. Salomon, Y. Ma, and M. Valiyaveettil Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype Nat Med 13 2007 1086 1095
19. A. Weidtmann, R. Scheithe, N. Hrboticky, A. Pietsch, R. Lorenz, and W. Siess Mildly oxidized LDL induces platelet aggregation through activation of phospholipase A2 Arterioscler Thromb Vasc Biol 15 1995 1131 1138
20. J.W. Akkerman From low-density lipoprotein to platelet activation Int J Biochem Cell Biol 40 2008 2374 2378
21. S.J.A. Korporaal, G. Gorter, H.J.M. van Rijn, and J.W.N. Akkerman Effect of oxidation on the platelet-activating properties of low density lipoprotein Arterioscler Thromb Vasc Biol 25 2005 1 7
22. D.-S. Chou, G. Hsiao, M.-Y. Shen, T.-H. Fong, C.-H. Lin, and T.-F. Chen Low Concentration of Oxidized Low Density Lipoprotein Suppresses Platelet Reactivity in vitro: An Intracellular Study Lipids 39 2004 433 440
23. S. Collot-Teixeira, F. Delorenzo, and J.L. McGregor Scavenger receptor A and CD36 are implicated in mediating platelet activation induced by oxidized low-density lipoproteins Arterioscler Thromb Vasc Biol 27 2007 2491 2492
24. K. Chen, M. Febbraio, W. Li, and R.L. Silverstein A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein Circ Res 102 2008 1512 1519
25. D.-S. Chou, C.-H. Chan, G. Hsiao, M.-Y. Shen, Y.-J. Tsai, and T.-F. Chen Inhibitory mechanisms of low concentrations of oxidized low-density lipoprotein on platelet aggregation J Biomed Sci 13 2006 333 343
26. R. Chen, X. Chen, R.G. Salomon, and T.M. McIntyre Platelet Activation by Low Concentrations of Intact Oxidized LDL Particles Involves the PAF Receptor Arterioscler Thromb Vasc Biol 29 2009 363 371
27. P. Seizer, K. Stellos, G. Selhorst, B.F. Krämer, M.R. Lang, and M. Gawaz CXCL16 is a novel scavenger receptor on platelets and is associated with acute coronary syndrome Thromb Haemost 105 2011 1112 1114
28. H. Yanai, H. Yoshida, Y. Hirowatari, Y. Tomono, and N. Tada Oxidized Low Density Lipoprotein Elevates Platelet Serotonin Release Am J Hematol 82 2007 684 689
29. C. Haug, C. Lenz, F. Díaz, and M.G. Bachem Oxidized Low-Density Lipoproteins Stimulate Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) Release by Coronary Smooth Muscle Cells Arterioscler Thromb Vasc Biol 24 2004 1823 1829
30. M.F. Brodde, S.J.A. Korporaal, G. Herminghaus, M. Fobker, T.J.C. Van Berkel, and U.J.F. Tietge Native high-density lipoproteins inhibit platelet activation via scavenger receptor BI Atherosclerosis 215 2011 374 382
31. M.T. Santos, J. Valles, A.J. Marcus, L.B. Safier, M.J. Broekman, and N. Islam Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes J Clin Invest 87 1991 571 580
32. A.E. May, T. Kalsch, S. Massberg, Y. Herouy, R. Schmidt, and M. Gawaz Engagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells Circulation 106 2002 2111 2117
33. J.R. Sheu, T.H. Fong, C.M. Liu, M.Y. Shen, T.L. Chen, and Y. Chang Expression of matrix metalloproteinase-9 in human platelets:regulation of platelet activation in in vitro and in vivo studies Br J Pharmacol 143 2004 193 201
34. V. Schmidt, T. Hilberg, G. Franke, D. Gläser, and H. Gabriel H.W. Paraformalde hyde fixation induces a systematic activation of platelets Platelets 14 2003 287 294
35. S. Panzer, L. Höcker, and D. Koren Agonists-induced platelet activation varies considerably in healthy male individuals: studies by flow cytometry Ann Hematol 85 2006 121 125
36. J. Curvers, J. de Wildt-Eggen, J. Heeremans, J. Scharenberg, D. de Korte, and P.F. van der Meer Flow cytometric measurement of CD62P (P-selectin) expression on platelets: a multicenter optimization and standardization effort Transfusion 48 2008 1439 1446
37. N.G. Ardlie, M.L. Selley, and L.A. Simons Platelet activation by oxidatively modified low density lipoproteins Atherosclerosis 76 1989 117 124
38. K.M. Naseem, A.H. Goodall, and K.R. Bruckdorfer Differential effects of native and oxidatively modified low-density lipoproteins on platelet function Platelets 8 1997 163 173
39. T. Holm, J.K. Damas, K. Holven, I. Nordøy, F.R. Brosstad, and T. Ueland CXC-chemokines in coronary artery disease: possible pathogenic role of interactions between oxidized low-density lipoprotein, platelets and peripheral blood mononuclear cells J Thromb Haemost 1 2003 257 262
40. Z. Wang, Q.W. Shi, S. Li, J. Du, J. Liu, and K.S. Dai Calmodulin antagonists induce platelet apoptosis Thromb Res 125 2010 340 350
41. V. Leytin, D.J. Allen, S. Mykhaylov, E. Lyubimov, and J. Freedman Thrombin-triggered platelet apoptosis J Thromb Haemost 4 2006 2656 2663
42. V. Leytin, D.J. Allen, S. Mykhaylov, L. Mis, E.V. Lyubimov, B. Garvey, and J. Freedman Pathologic high shear stress induces apoptosis events in human platelets Biochem Biophys Res Commun 320 2 2004 303 310
43. Z. Wang, Q.W. Shi, S. Li, J. Du, J. Liu, and K.S. Dai Hyperthermia induces platelet apoptosis and glycoprotein Ib aectodomain shedding Platelets 21 3 2010 229 237
44. H. Chen, D. Li, T. Saldeen, and J.L. Mehta Transforming growth factor-beta (1) modulates oxidatively modified LDL-induced expression of adhesion molecules: role of L OX- 1 Circ Res 89 2001 1155 1160
45. C. Hu, A. Dandapat, L. Sun, J.A. Khan, Y. Liu, and P.L. Hermonat Regulation of TGFbeta1-mediated collagen formation by LOX-1: studies based on forced over expression of TGFbeta1 in wild-type and lox-1 knock-out mouse cardiac fibroblasts J Biol Chem 283 2008 10226 10231
46. M.Y. Chen, M.K. Kakutani, T. Naruko, M. Ueda, S. Narumiya, and T. Masaki Activation-Dependent Surface Expression of LOX-1 in Human Platelets Biochem Biophys Res Commun 282 2001 153 158
47. J.L. Mehta, N. Sanada, C.P. Hu, J.W. Chen, A. Dandapat, and F. Sugawara Deletion of LOX-1 Reduces Atherogenesis in LDLR Knockout Mice Fed High Cholesterol Diet Circ Res 100 2007 1634 1642
48. J.R. Nofer, M.F. Brodde, and B.E. Kehrel High-density lipoproteins, platelets and the pathogenesis of atherosclerosis Clin Exp Pharmacol Physiol 37 2010 726 735
49. S.J. Korporaal, and J.W. Akkerman Platelet activation by low density lipoprotein and high density lipoprotein Pathophysiol Haemost Thromb 35 2006 270 280
50. Y. Ma, M.Z. Ashraf, and E. Podrez Scavenger receptor BI modulates platelet reactivity and thrombosis in dyslipidemia Blood 116 2010 1932 1941
51. S.J. Korporaal, I. Meurs, A.D. Hauer, R.B. Hildebrand, M. Hoekstra, and H.T. Cate Deletion of the high-density lipoprotein receptor scavenger receptor BI in mice modulates thrombosis susceptibility and indirectly affects platelet function by elevation of plasma free cholesterol Arterioscler Thromb Vasc Biol 31 2011 34 42
52. B. Fuhrman, N. Volkova, and M. Aviram Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from atherosclerotic mice: protective role of antioxidants and of paraoxonase Atherosclerosis 161 2002 307 316
53. J. Hulthe, and B. Fagerberg Circulating Oxidized LDL Is Associated With Subclinical Atherosclerosis Development and Inflammatory Cytokines(AIR Study) Arterioscler Thromb Vasc Biol 22 2002 1162 1167
54. T. Naruko, M. Ueda, S. Ehara, A. Itoh, K. Haze, and N. Shirai Persistent High Levels of Plasma Oxidized Low-Density Lipoprotein After Acute Myocardial Infarction Predict Stent Restenosis Arterioscler Thromb Vasc Biol 26 2006 877 883
55. K. Shimada, H. Mokuno, E. Matsunaga, T. Miyazaki, K. Sumiyoshi, and K. Miyauchi Circulating oxidized low-density lipoprotein is an independent predictor for cardiac event in patients with coronary artery disease Atherosclerosis 174 2004 343 347
56. K. Stellos, R. Sauter, M. Fahrleitner, J. Grimm, D. Stakos, and F. Emschermann Binding of Oxidized Low-Density Lipoprotein on Circulating Platelets Is increased in Patients With Acute Coronary Syndromes and Induces Platelet Adhesion to Vascular Wall In Vivo - Brief Report Arterioscler Thromb Vasc Biol 2012 32-00